In the past few years, inflammation has emerged as a major driving force of atherosclerotic lesion devel-opment. It is now well-established that from early lesion to vulnerable plaque formation, numerous cel-lular and molecular inflammatory components participate in the disease process. The most prominent cells that invade in evolving lesions are monocyte-derived macrophages and T-lymphocytes. Both cell types produce a wide array of soluble inflammatory mediators (cytokines, chemokines) which are criti-cally important in the initiation and perpetuation of the disease. This review summarizes the currently available information from mouse studies on the contribution of a specified group of cytokines expresse
The regulatory mechanisms of the inflammatory process in the atherosclerotic plaque are still not cl...
Infiltration of leukocyte subsets is a driving force of atherosclerotic lesion growth, and during th...
Atherosclerosis initiation and progression is controlled by inflammatory molecular and cellular medi...
In the past few years, inflammation has emerged as a major driving force of atherosclerotic lesion d...
Atherosclerosis, a chronic inflammatory disorder of the arteries, is responsible for most deaths in ...
Atherosclerosis is the pathological process that underlies the development of cardiovascular disease...
International audienceAtherosclerosis is a chronic disease of the arterial wall where both innate an...
Chronic inflammation driven by immune responses to lipid deposition in the arterial wall is now unde...
AbstractAtherosclerosis, a chronic inflammatory disorder of the arteries, is responsible for most de...
Atherosclerosis is mainly considered to be a chronicinflammatory disease.1,2 The importance of infla...
Atherosclerosis is a complex chronic inflammatory and metabolic disease that involves the collaborat...
Atherosclerosis is a complex chronic inflammatory and metabolic disease that involves the collaborat...
Atherosclerosis is an inflammatory and multifaceted disorder resulting from the accumulation of lipi...
The notion of atherosclerosis as a chronic inflammatory disease has intensified research on the role...
Background: While the impact of inflammation as the substantial driving force of atherosclerosis has...
The regulatory mechanisms of the inflammatory process in the atherosclerotic plaque are still not cl...
Infiltration of leukocyte subsets is a driving force of atherosclerotic lesion growth, and during th...
Atherosclerosis initiation and progression is controlled by inflammatory molecular and cellular medi...
In the past few years, inflammation has emerged as a major driving force of atherosclerotic lesion d...
Atherosclerosis, a chronic inflammatory disorder of the arteries, is responsible for most deaths in ...
Atherosclerosis is the pathological process that underlies the development of cardiovascular disease...
International audienceAtherosclerosis is a chronic disease of the arterial wall where both innate an...
Chronic inflammation driven by immune responses to lipid deposition in the arterial wall is now unde...
AbstractAtherosclerosis, a chronic inflammatory disorder of the arteries, is responsible for most de...
Atherosclerosis is mainly considered to be a chronicinflammatory disease.1,2 The importance of infla...
Atherosclerosis is a complex chronic inflammatory and metabolic disease that involves the collaborat...
Atherosclerosis is a complex chronic inflammatory and metabolic disease that involves the collaborat...
Atherosclerosis is an inflammatory and multifaceted disorder resulting from the accumulation of lipi...
The notion of atherosclerosis as a chronic inflammatory disease has intensified research on the role...
Background: While the impact of inflammation as the substantial driving force of atherosclerosis has...
The regulatory mechanisms of the inflammatory process in the atherosclerotic plaque are still not cl...
Infiltration of leukocyte subsets is a driving force of atherosclerotic lesion growth, and during th...
Atherosclerosis initiation and progression is controlled by inflammatory molecular and cellular medi...